全文获取类型
收费全文 | 38343篇 |
免费 | 3035篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 291篇 |
儿科学 | 1706篇 |
妇产科学 | 1184篇 |
基础医学 | 5185篇 |
口腔科学 | 402篇 |
临床医学 | 4651篇 |
内科学 | 7012篇 |
皮肤病学 | 681篇 |
神经病学 | 4513篇 |
特种医学 | 722篇 |
外科学 | 3710篇 |
综合类 | 353篇 |
现状与发展 | 1篇 |
一般理论 | 74篇 |
预防医学 | 5223篇 |
眼科学 | 596篇 |
药学 | 2509篇 |
中国医学 | 35篇 |
肿瘤学 | 2611篇 |
出版年
2024年 | 81篇 |
2023年 | 618篇 |
2022年 | 989篇 |
2021年 | 1951篇 |
2020年 | 1156篇 |
2019年 | 1674篇 |
2018年 | 1881篇 |
2017年 | 1271篇 |
2016年 | 1438篇 |
2015年 | 1494篇 |
2014年 | 1960篇 |
2013年 | 2461篇 |
2012年 | 3566篇 |
2011年 | 3449篇 |
2010年 | 1726篇 |
2009年 | 1483篇 |
2008年 | 2274篇 |
2007年 | 2365篇 |
2006年 | 1998篇 |
2005年 | 1833篇 |
2004年 | 1566篇 |
2003年 | 1293篇 |
2002年 | 1165篇 |
2001年 | 146篇 |
2000年 | 107篇 |
1999年 | 176篇 |
1998年 | 230篇 |
1997年 | 136篇 |
1996年 | 114篇 |
1995年 | 114篇 |
1994年 | 106篇 |
1993年 | 96篇 |
1992年 | 53篇 |
1991年 | 45篇 |
1990年 | 40篇 |
1989年 | 29篇 |
1988年 | 24篇 |
1987年 | 23篇 |
1986年 | 28篇 |
1985年 | 31篇 |
1984年 | 30篇 |
1983年 | 24篇 |
1982年 | 25篇 |
1981年 | 26篇 |
1980年 | 29篇 |
1979年 | 17篇 |
1978年 | 15篇 |
1977年 | 10篇 |
1974年 | 8篇 |
1972年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
21.
22.
Balanced analgesia (an opioid and a nonsteroidal anti-inflammatory agent) after hysterectomy often leads to better postoperative pain outcomes. Researchers compared post-hysterectomy patients who received balanced analgesia with those who received only morphine patient-controlled analgesia, and their relationship with pain scores, ambulation, and hospital length of stay. 相似文献
23.
24.
Sarah J Buckley 《British medical journal》2005,331(7518):698-699
25.
Amit Badhwar Thomas L Forbes Marge B Lovell Alison A Dungey Sarah D McCarter Jeffrey R Scott Guy DeRose Kenneth A Harris Richard F Potter 《Canadian journal of surgery》2004,47(5):352-358
BACKGROUND: Ischemic preconditioning (IPC) has been found in animals to have a protective effect against future ischemic injury to muscle tissue. Such injury is unavoidable during some surgical procedures. To determine whether chronic ischemia in the lower extremities would imitate IPC and reduce ischemic injury during vascular surgery, we designed a controlled clinical study. PATIENTS AND METHODS: Two groups of patients at a university-affiliated medical centre with chronic lower-extremity ischemia served as models of IPC: 6 patients awaiting femoral distal bypass (FDB) and 4 scheduled for aortobifemoral (ABF) bypass grafting for aortoiliac occlusive disease. Seven patients undergoing elective open repair of an infrarenal abdominal aortic aneurysm (AAA) were chosen as non-IPC controls. Three hematologic indicators of skeletal-muscle injury, lactate dehydrogenase (LDH), creatine kinase (CK) and myoglobin, were measured before placement of the proximal clamp, during surgical ischemia, immediately upon reperfusion, 15 minutes after and 1 hour after reperfusion, and during the first, second and third postoperative days. RESULTS: Baseline markers of skeletal-muscle injury were similar in all groups. In postreperfusion samples, concentrations of muscle-injury markers were significantly lower in the 2 PC groups than in the control group. For example, at day 2, LDH levels were increased by about 30% over baseline measures in the elective AAA (control) group, whereas levels in the FDB and ABF groups remained statistically unchanged from baseline. Myoglobin in controls had increased by 977%, but only by 160% in the FDB and 528% in the ABF groups. CK levels, in a similar trend, were 1432% higher in the control group and only 111% (FDB) and 1029% (ABF) in the study groups. Taken together, these data represent a significant level of protection. CONCLUSIONS: Patients with chronic lower-extremity ischemia suffered less severe ischemic injury after a period of acute ischemia than those with acute ischemia alone. Ischemic preconditioning is one proposed mechanism to help explain this protective effect. 相似文献
26.
27.
28.
Monica Conciatori Christopher J Stodgell Susan L Hyman Melanie O'Bara Roberto Militerni Carmela Bravaccio Simona Trillo Francesco Montecchi Cindy Schneider Raun Melmed Maurizio Elia Lori Crawford Sarah J Spence Lucianna Muscarella Vito Guarnieri Leonardo D'Agruma Alessandro Quattrone Leopoldo Zelante Daniel Rabinowitz Tiziana Pascucci Stefano Puglisi-Allegra Karl-Ludvig Reichelt Patricia M Rodier Antonio M Persico 《Neuropsychopharmacology》2004,55(4):413-419
BACKGROUND: The HOXA1 gene plays a major role in brainstem and cranial morphogenesis. The G allele of the HOXA1 A218G polymorphism has been previously found associated with autism. METHODS: We performed case-control and family-based association analyses, contrasting 127 autistic patients with 174 ethnically matched controls, and assessing for allelic transmission disequilibrium in 189 complete trios. RESULTS: A, and not G, alleles were associated with autism using both case-control (chi(2) = 8.96 and 5.71, 1 df, p <.005 and <.025 for genotypes and alleles, respectively), and family-based (transmission/disequilibrium test chi(2) = 8.80, 1 df, p <.005) association analyses. The head circumference of 31 patients carrying one or two copies of the G allele displayed significantly larger median values (95.0th vs. 82.5th percentile, p <.05) and dramatically reduced interindividual variability (p <.0001), compared with 166 patients carrying the A/A genotype. CONCLUSIONS: The HOXA1 A218G polymorphism explains approximately 5% of the variance in the head circumference of autistic patients and represents to our knowledge the first known gene variant providing sizable contributions to cranial morphology. The disease specificity of this finding is currently being investigated. Nonreplications in genetic linkage/association studies could partly stem from the dyshomogeneous distribution of an endophenotype morphologically defined by cranial circumference. 相似文献
29.
30.
David G Hicks Brian J Yoder Sarah Short Shannon Tarr Nichole Prescott Joseph P Crowe Andrea E Dawson G Thomas Budd Steven Sizemore Muzaffer Cicek Toni K Choueiri Raymond R Tubbs Daniel Gaile Norma Nowak Mary Ann Accavitti-Loper Andra R Frost Danny R Welch Graham Casey 《Clinical cancer research》2006,12(22):6702-6708
PURPOSE: This study aims to determine the effect of loss of breast cancer metastasis suppressor 1 (BRMS1) protein expression on disease-free survival in breast cancer patients stratified by estrogen receptor (ER), progesterone receptor (PR), or HER2 status, and to determine whether loss of BRMS1 protein expression correlated with genomic copy number changes. EXPERIMENTAL DESIGN: A tissue microarray immunohistochemical analysis was done on tumors of 238 newly diagnosed breast cancer patients who underwent surgery at the Cleveland Clinic between January 1, 1995 and December 31, 1996, and a comparison was made with 5-year clinical follow-up data. Genomic copy number changes were determined by array-based comparative genomic hybridization in 47 breast cancer cases from this population and compared with BRMS1 staining. RESULTS: BRMS1 protein expression was lost in nearly 25% of cases. Patients with tumors that were PR negative (P=0.006) or HER2 positive (P=0.039) and <50 years old at diagnosis (P=0.02) were more likely to be BRMS1 negative. No overall correlation between BRMS1 staining and disease-free survival was observed. A significant correlation, however, was seen between loss of BRMS1 protein expression and reduced disease-free survival when stratified by either loss of ER (P=0.008) or PR (P=0.029) or HER2 overexpression (P=0.026). Overall, there was poor correlation between BRMS1 protein staining and copy number status. CONCLUSIONS: These data suggest a mechanistic relationship between BRMS1 expression, hormone receptor status, and HER2 growth factor. BRMS1 staining could potentially be used in patient stratification in conjunction with other prognostic markers. Further, mechanisms other than genomic deletion account for loss of BRMS1 gene expression in breast tumors. 相似文献